2018 American Transplant Congress
Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC
Objective: Prognosticating outcomes in liver transplant (LT) for hepatocellular carcinoma (HCC) continues to challenge the field. Whereas adoption of the binary Milan Criteria (MC) generalized…2018 American Transplant Congress
Impact of ELAD C3A Cell Conditioned Medium Enhanced Perfusate Fluid on Functional Recovery of Extended Criteria Donor Livers during Normothermic Machine Perfusion
Reconditioning of donor livers by Normothermic Machine Perfusion (NMP) is already increasing the numbers of transplantable organs from the extended criteria donors. The hepatoblastoma-derived cell…2018 American Transplant Congress
Factors Influencing Post-Transplant Mortality in Primary Biliary Cholangitis
Introduction: Primary Biliary Cholangitis (PBC) is a significant cause of end stage liver disease and hepatocellular carcinoma necessitating liver transplant. Little data exists on the…2018 American Transplant Congress
Non-US Citizen Liver Transplant Recipients (LTR) Have Superior Outcomes Compared to US Citizen LTR: A Retrospective Study of 50,422 Subjects Using the Organ Procurement and Transplant Network (OPTN) from 1992-2015
The US performs over 7,000 liver transplants per year and a substantial subset of Non-US citizen recipients exist. United Network for Organ Sharing (UNOS) policy…2018 American Transplant Congress
Qualitative Analysis of Facebook Posts Created via the Donor Application
The Donor App is a smartphone app that helps transplant candidates create a Facebook (FB) post telling their story about organ failure and their need…2018 American Transplant Congress
Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma Treated with Neoadjuvant Therapy: A Pilot Cohort Study
1Houston Methodist Hospital, Houston, TX; 2MD Anderson Cancer Center, Houston, TX.
INTRODUCTIONIntrahepatic cholangiocarcinoma (iCCA) is a well-recognized contraindication for liver transplantation (LT). Recent reports indicate favorable LT outcomes for early iCCA (<2cm), but, poor survival persists…2018 American Transplant Congress
Blood Transfusion is a Critical Determinant of Resource Utilization and Total Hospital Cost in Liver Transplantation
Surgery, University of Kentucky, Lexington.
Objective: The aim of this study is to identify factors associated with increased resource use and total hospital cost after liver transplantation (LT).Methods: A study…2018 American Transplant Congress
Factors Associated with Listing for Liver Transplantation in an OPO Other Than the Resident OPO
Geographic disparity in access to liver transplantation has been well described. Candidates may travel to be listed in OPOs with better access. We hypothesized that…2018 American Transplant Congress
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients
There is a potential to improve patient satisfaction as well as access to liver transplantation (LT). AIM: This study evaluated outcomes of LT recipients whose…2018 American Transplant Congress
Clinical Impacts of Deceased Donor Oxygenation Status in Liver Transplant
Background: PaO2/FiO2 (P/F) ratio of > 300 mmHg in donors is a criterion of standard lung donors, while several studies demonstrated that the utilization of…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 180
- Next Page »